---
title: BioAgilytix vs Solvias
slug_a: bioagilytix
slug_b: solvias
site: cro
review_signal_gate: closed
canonical_path: /compare/bioagilytix/solvias
---

# BioAgilytix vs Solvias

Side-by-side profile data from each company listing on this directory.

## BioAgilytix

- Profile: [/companies/bioagilytix](/companies/bioagilytix)

BioAgilytix — Bioanalytical CRO specializing in pharmacokinetics, immunogenicity, biomarkers, and CMC analytics with 30+ years of experience and 1,100+ employees conducting 5M+ tests annually.

Services: 11. Modalities: 4. Indications: 0. Locations: 8. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Flow Cytometry Services
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Analytical Method Development & Validation
- ICH Stability Studies
- Virology Services

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Vaccine

### Indications

- Data not yet provided.

### Phases

- Discovery
- Preclinical (General)
- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)

## Solvias

- Profile: [/companies/solvias](/companies/solvias)

Solvias — Global cGMP contract research organization providing comprehensive analytical services for drug development, from preclinical through commercialization, with expertise in biologics, cell & gene therapies, and small molecules.

Services: 8. Modalities: 5. Indications: 0. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Analytical Method Development & Validation
- ICH Stability Studies
- Cell-Line Development
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- Extractables & Leachables Studies
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy

### Indications

- Data not yet provided.

### Phases

- Preclinical (General)
- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)